Soluble epoxide hydrolase in mammals diminishes the body's ability to self-repair

March 15, 2019, University of Minnesota
Soluble epoxide hydrolase in mammals diminishes the body’s ability to self-repair
Mammalian soluble epoxide hydrolase (sEH) enzyme. Credit: HAIRUN LI

In the 1980s, researchers at the University of California, Riverside, were looking for a way to control insects and found an enzyme—called JHEH—that, when inhibited, prevents caterpillars from becoming butterflies. This work led to the discovery of an equivalent enzyme in mammals, called soluble epoxide hydrolase or sEH.

After spending a few years at UC Davis, Alonso Guedes, DVM, MS, Ph.D., associate professor of Anesthesia and Pain Medicine in the Department of Veterinary Clinical Sciences, joined the University of Minnesota, where he is working to further understand how to use sEH to advance in veterinary—and eventually human—medicine.

"We mammals have a similar ," Guedes says. "However, most of us don't undergo metamorphosis," he adds with a smile. "We autoregulate and self-repair. And in mammals, the presence of this enzyme has the opposite effect—it diminishes the body's ability to self-repair. Inhibiting it actually allows our cells to do their work."

Guedes and his team are working to understand how blocking this enzyme can help improve mammal health, starting with horses suffering from —a severely painful disease in the hoof that makes horses (and other hoofed animals such as sheep, goats, and cattle) unable to walk, develop, or behave normally. Most horses with laminitis do not respond well to current pain medications and treatments, and euthanasia is currently the primary outcome for severe cases.

"A horse's hoof is like a human nail, except they stand on it all day long," says Guedes. "The hoof wall is attached to the bone by a very tough tissue that interconnects like a zipper, which is called the digital laminae. Certain proteins hold the digital laminae together, and when there is inflammation, such as with laminitis, those proteins break down and the hoof's connection to the bone breaks apart."

Guedes and his team want to know if sEH is involved in the breakdown of these important proteins, and they are already seeing evidence confirming this in mice. "It seems like inhibiting the enzyme could potentially protect some of the linking proteins that hold the tissues together in the hoof," he says. They've developed a compound that inhibits the enzyme and allows for more blood flow and delivery of nutrients to a harmed area.

But crucial questions remain. Primarily, would inhibiting the enzyme allow the body to repair already-damaged proteins and cells? Secondly, at what rate does inhibiting the enzyme slow the process of deterioration? But most importantly, could we prevent damage and deterioration by intervening early on?

At the University of Minnesota College of Veterinary Medicine's Large Animal Hospital, Guedes has used the experimental compound on a few different equine patients with laminitis as well as arthritis. In many cases, the compound works in conjunction with a pain medication to provide the animal both pain relief and bodily recovery. Results for many of Guedes' patients have been visible within a matter of days.

A similar compound has been tested in and resulted in improved outcomes for patients with neuropathy. And its effect on arthritis in could have implications on human arthritis in the future, too. Recently, Guedes and Troy Trumble, DVM, MS, Ph.D., associate professor in the Department of Veterinary Population Medicine, were awarded two small but critical grants to further their research into this compound's ability to inhibit sEH and alleviate and mobility limitations for equine patients with .

"We want to understand how this enzyme is working and how we can fine tune it to better use it to promote health," says Guedes.

Explore further: Tests set for experimental drug for laminitis

Related Stories

Tests set for experimental drug for laminitis

November 16, 2012

(—Veterinarians at the University of California, Davis, School of Veterinary Medicine have announced plans to conduct the first clinical trial of an experimental drug that has shown promise in treating horses stricken ...

Free access to research will help save horses and ponies

February 15, 2019

Laminitis—a complex, common and often devastating disease—is the second biggest killer of domestic horses. Now a body of important research on it has been compiled and shared online for equine vets and others to access.

Researchers address equine disease

February 19, 2014

It is a disease that has taken the life of Black Caviar's brother, the most expensive yearling sold at public auction in Australia, but to the average horse owner laminitis is a killer that often strikes without warning.

Recommended for you

Coffee-based colloids for direct solar absorption

March 22, 2019

Solar energy is one of the most promising resources to help reduce fossil fuel consumption and mitigate greenhouse gas emissions to power a sustainable future. Devices presently in use to convert solar energy into thermal ...

Paleontologists report world's biggest Tyrannosaurus rex

March 22, 2019

University of Alberta paleontologists have just reported the world's biggest Tyrannosaurus rex and the largest dinosaur skeleton ever found in Canada. The 13-metre-long T. rex, nicknamed "Scotty," lived in prehistoric Saskatchewan ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.